Also trades as: MAYNF (OTC) · $vol 0M
MYX.AX ASX
Mayne Pharma Group Limited
1W: +1.4%
1M: -8.4%
3M: -1.0%
YTD: +0.3%
1Y: -45.1%
3Y: -19.0%
5Y: -52.3%
A$2.82 ($1.96)
-0.03 (-1.05%)
Weekly Expected Move ±5.6%
A$3
A$3
A$3
A$3
A$3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$16M
-10.6% ▼
5Y CAGR: -19.9%
Capital Expenditures
$3M
+76.0% ▲
5Y CAGR: -34.9%
Free Cash Flow
$13M
+144.1% ▲
5Y CAGR: -10.6%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$20M
+139.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$209M | -$317M | -$169M | -$94M | $31M |
| Depreciation & Amort. | $55M | $65M | $72M | $73M | $64M |
| Stock-Based Comp. | $5M | $7M | $4M | $4M | $0 |
| Change in Working Capital | -$9M | $145M | -$15M | $43M | $12M |
| Other Non-Cash Items | $88M | $7M | $92M | -$8M | -$93M |
| Operating Cash Flow | -$7M | -$43M | -$15M | $17M | $16M |
| — Investing Activities — | |||||
| Capital Expenditures | -$12M | -$220M | -$8M | -$12M | -$3M |
| Acquisitions (Net) | $5M | $842M | $7M | $0 | $0 |
| Investment Purchases | $0 | -$128M | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $89M | $0 | $39M |
| Other Investing | -$22M | -$22M | -$35M | -$56M | -$26M |
| Investing Cash Flow | -$29M | $473M | $53M | -$68M | $10M |
| — Financing Activities — | |||||
| Net Debt Issuance | $40M | -$376M | -$11M | -$4M | $0 |
| Stock Repurchased | $0 | -$6M | -$11M | -$148K | $0 |
| Dividends Paid | $0 | -$45M | $0 | $0 | $0 |
| Other Financing | -$12M | -$4M | $2M | $3M | -$3M |
| Financing Cash Flow | $28M | -$431M | -$20M | -$556K | -$3M |
| Net Change in Cash | -$1M | -$4M | $17M | -$50M | $20M |
| Cash End of Period | $97M | $102M | $110M | $60M | $82M |
| Free Cash Flow | -$28M | -$263M | -$36M | $5M | $13M |